The outcomes are in and they add to the evidence of why the industry needs to reconsider its approach because how can any process lacking clear ministerial direction and administered by antagonistic officials possibly end well?
Final outcomes add to the evidence of the need for a new approach
December 8, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
TGA approves first-of-a-kind medicine for early symptomatic Alzheimer’s disease
May 21, 2025 - - Latest News -
Examples are important as evidence of the problem, but be prepared to defend them
May 21, 2025 - - Latest News -
Trump administration invites companies to 'align' US pricing under MFN plan
May 21, 2025 - - Latest News -
NDIS minister restates the importance of 'nothing about us, without us!'
May 20, 2025 - - Latest News -
Industry alarm over the sudden pursuit of surprise uncertified claims
May 20, 2025 - - Latest News -
Medicines Australia sharpens post-election language on reform
May 20, 2025 - - Latest News -
Report highlights international confidence in Australian clinical trials
May 19, 2025 - - Latest News